Skip to main content

Table 2 Patient characteristics. Data are shown as mean ± SD or counts (%)

From: Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation

CharacteristicTotal
N = 86
IM HBIG
N = 59
IV HBIG
N = 27
P value*
Gender   0.13
 Male68 (79.1)44 (74.6)24 (88.9) 
 Female18 (20.9)15 (25.4)3 (11.1) 
Age56.6 ± 10.355.8 ± 10.858.4 ± 9.00.41
Occupation   0.04
 Employed, full time/part time25 (29.1)21 (35.6)4 (15.4) 
 Unemployed6 (7.0)4 (6.8)2 (7.7) 
 Retired41 (47.7)25 (42.4)16 (61.5) 
 Housewife11 (12.8)9 (15.3)2 (7.7) 
 Other3 (3.5)0 (0.0)2 (7.7) 
Years of school education   0.58
 ≤ 5 years26 (30.2)18 (31.0)8(30.8) 
 6–8 years27 (31.4)18 (31.0)9 (34.6) 
 9–13 years27 (31.4)18 (31.0)9 (34.6) 
 > 13 years4 (4.7)4 (4.9)0 (0.0) 
 Not reported2 (2.3)1 (1.7)1 (3.7) 
Marital status   0.20
 Single15 (17.4)13 (22.0)2 (7.7) 
 Married61 (70.9)39 (66.1)22 (84.6) 
 Divorced/widowed9 (10.6)7 (11.9)2 (7.6) 
 Not reported1 (1.2)0 (0.0%)1 (3.8) 
Living alone13 (15.1)12 (20.7)1 (3.8)0.06
Years after LT8.5 ± 5.98.6 ± 5.98.3 ± 6.10.72
Previous hepatocellular carcinoma31 (36.0)21 (36.8)10 (37.0)0.98
Diabetes18 (20.9)13 (22.0)5 (18.5)0.71
Hypertension31 (36.0)22 (37.3)9 (33.3)0.72
Obesity11 (12.8)10 (16.9)1 (3.7)0.16
  1. HBIG hepatitis B immunoglobulin, IM intramuscular, IV intravenous, LT liver transplantation
  2. *P value for IM versus IV HBIG (Mann-Whitney U-test for continuous variables; chi square or Fisher exact test for categorical variables)